论文部分内容阅读
美国IMS保健公司最近宣布,它已与China Metrik公司合并经营,成为提供中国医药市场信息的令人瞩目的来源。 新成立的IMS China Metrik公司将致力于新产品的开发,并推行进一步提供市场分析质量的各项计划,为美国及跨国医药公司提供在中国的营业服务,IMS China Metrik公司将延用China Metrik公司的工作人员,在全中国开发软件和培训药剂师。 卡特先生还宣布任命罗任(Luo Ren音译)先生为主管经营的中国公司副经理,任命徐曼迪(Mandy chui音译)女士为
US IMS Healthcare recently announced that it has merged with China Metrik to become an impressive source of information for the Chinese pharmaceutical market. The newly-established IMS China Metrik Company will be committed to the development of new products and will implement various plans to further provide market analysis quality. It will provide US and multinational pharmaceutical companies with business services in China, and IMS China Metrik will extend the use of China Metrik Corporation. The staff developed software and trained pharmacists throughout China. Mr. Carter also announced the appointment of Mr. Luo Ren, a deputy manager of a Chinese company in charge of management, and Ms. Mandy Chui